- Home
- WEC vs MDLN Comparison
WEC vs MDLN Comparison
Compare WEC & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WEC | MDLN |
|---|---|---|
| Founded | 1896 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8B | 30.7B |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | WEC | MDLN |
|---|---|---|
| Price | $117.80 | $39.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 27 |
| Target Price | ★ $118.50 | $45.35 |
| AVG Volume (30 Days) | 2.9M | ★ 10.0M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.81 | 0.45 |
| Revenue | $9,800,100,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $5.24 | $10.44 |
| Revenue Next Year | $6.03 | $8.07 |
| P/E Ratio | ★ $24.44 | $89.88 |
| Revenue Growth | ★ 13.96 | 11.47 |
| 52 Week Low | $99.80 | $31.37 |
| 52 Week High | $120.15 | $50.88 |
Technical Indicators
Market Signals| Indicator | WEC | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 67.69 | 65.38 |
| Support Level | $110.16 | $35.41 |
| Resistance Level | $118.91 | $43.31 |
| Average True Range (ATR) | 1.99 | 1.63 |
| MACD | 0.05 | 0.64 |
| Stochastic Oscillator | 75.23 | 81.54 |
Price Performance
Historical ComparisonAbout WEC WEC Energy Group Inc.
WEC Energy Group's electric and gas utility businesses serve electric and gas customers in Illinois, Michigan, Minnesota, and Wisconsin service territories. The company also owns a 60% stake in American Transmission Co. WEC's asset mix is approximately 49% electric generation and distribution, 30% gas distribution, 10% electric transmission, 9% unregulated renewable energy, and 2% LNG distribution and generation.
About MDLN Medline Inc. Class A Common Stock
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.